Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma
Novartis
Novartis
University of California, Davis
Swiss Cancer Institute
Fred Hutchinson Cancer Center
Duke University
Case Comprehensive Cancer Center
City of Hope Medical Center